The change was approved by the UN Statistical Commission in March 2025 and applied retrospectively when the 2025 Global Monitoring Report rebuilt the time series. Under the revised definition, the share of the world’s population facing financial hardship in 2019 was 12.7 percentage points higher than the superseded measure had implied. The revision restored, in modified form, a capacity-to-pay approach proposed in 2003: it retained the 40% threshold and the logic of measuring payment against resources left after basic needs, but replaced a food-based subsistence deduction with a societal poverty line and changed the treatment of the poorest households. The policy brief describes this sequence not as definitive convergence on a single true measure, but as a shift in the balance among competing values, including comparability and equity.

The mathematical effect is substantial. Let c represent daily per-capita consumption or income, o out-of-pocket health payment and z the societal poverty line. The revised discretionary budget is d=c−z, and household members are counted when o>0 and o>0.4d. A household at or below the poverty line therefore has a zero or negative discretionary budget, so any positive payment qualifies. In the hypothetical examples used in the brief, a household consuming USD 2.50 per person per day and paying USD 0.10 for health was not counted under the old 10% rule but is counted as impoverishing under the new measure. By contrast, a household consuming USD 12 and paying USD 2, or 16.7% of total consumption, was counted under the old rule but not the revised one because the payment was below 40% of its USD 8.85 discretionary budget. The threshold rises with resources, reaching nearly 40% of total consumption for the best-off households.

India illustrates why the revised household measure cannot be confused with the country’s headline national-accounts ratio. The National Health Accounts estimate of out-of-pocket expenditure as a share of total health expenditure fell from 64.2% in 2013–14 to 39.4% in 2021–22, then rose to 43.4% in 2022–23. These are aggregate ratios describing how the national health bill was financed, not estimates of the number of households whose payments crossed a hardship threshold. In the accounts, government expenditure is part of the denominator, so the ratio can move because public spending changes even when household payments do not. The figures are also presented in nominal national totals, with the out-of-pocket component modelled partly from survey rounds rather than observed annually.

The arithmetic behind India’s 2021–22 low point is important. Published aggregates show household out-of-pocket spending rising from INR 3.28 lakh crore in 2020–21 to INR 3.56 lakh crore in 2021–22 and INR 3.83 lakh crore in 2022–23. The ratio fell in 2021–22 because total health expenditure grew faster than household spending: total health expenditure rose 22.3% and government health expenditure 37.2%. In 2022–23, government health expenditure fell 11.2% and total health expenditure fell 2.6% while out-of-pocket spending continued to grow. India’s health ministry attributes the earlier trough to one-off pandemic response and vaccination outlays. The published series is consistent with that explanation, but the brief does not establish how much of the movement it explains, because it does not calculate a counterfactual, deflate the figures, convert them to real per-person amounts or identify which households paid.

Population-level coverage figures also do not directly measure financial protection. The National Sample Survey 80th round, fielded through 2025, reported insurance coverage of 47.4% of rural people and 44.3% of urban people, compared with 14.1% and 19.1% in 2017–18. The same survey reported a median payment of INR 24,000 across private hospitalisations, excluding childbirth, covering insured and uninsured people; the private-hospital category included hospitals empanelled under government financing schemes. It therefore cannot be interpreted as the payment made by an insured household or as a combined public-and-private figure. The survey also found average hospitalisation payments of INR 6,631 in public facilities and INR 50,508 in private facilities, excluding childbirth; for childbirth, the corresponding amounts were INR 2,299 and INR 37,630, while institutional delivery accounted for 96.2% of births. These findings show that provider type and payment distributions matter, while coverage statistics alone do not reveal whether patients are protected.

The revised indicator also leaves one form of financial hardship largely invisible. Indicator 3.8.2 is built from payments made, so a household that needs care but does not seek it records no expenditure and is not classified as facing hardship. The brief proposes a companion measure among people reporting an ailment: the share who did not obtain care and gave a financial reason, such as treatment costs, transport expenses or lost earnings. Other reasons, including distance, waiting times, quality concerns or a judgement that illness did not require treatment, should be reported separately rather than pooled into a single rate. Such a measure would remain conditional on illness being reported and would miss need that was never perceived or never disclosed, but most national household surveys already collect information on treatment sought and reasons for not seeking it.

India’s survey data show why this missing measure matters while also illustrating its limits. The 2025 round recorded an ailment for 13.1% of people within a 15-day window, compared with 7.5% in 2017–18. The brief cautions that this near-doubling cannot be read as proof of a comparable increase in underlying disease burden: the rounds differed in timing, questionnaire and context, while post-pandemic symptom recognition and contact with the health system may have changed. The comparison is therefore a change in reported illness, not a measured trend in need. Within 2025, urban residents reported more illness than rural residents, 14.9% compared with 12.2%, even though rural residents used public facilities more often when they obtained care. Self-reported morbidity can understate need where expectations are low and overstate it where medical contact is frequent, making it an imperfect denominator for forgone care.

Based on the documentary review, the brief recommends six changes to health-financing measurement, four of which can be implemented with data already collected. Custodian agencies should publish old and revised series together during the transition, and empirical claims should identify the threshold, denominator, indicator version and survey instrument. Statistical offices should report the impoverishing and non-impoverishing components of the revised measure separately. Health ministries and national-accounting agencies should publish real, per-capita out-of-pocket and government health spending alongside the aggregate ratio and flag years containing one-off public outlays. National statistical offices should cross-tabulate insurance status, provider type and payment per episode. A harmonised companion measure of financially attributed forgone care is also recommended, although it requires agreed definitions and reporting periods. The central lesson is that no single headline can establish financial protection: household measures show whether payments caused hardship, national accounts show how the health bill was financed, and forgone-care measures reveal who never paid because they did not obtain treatment.

Subject of Research: Measurement of financial protection, health expenditure and forgone care after the 2025 revision of SDG indicator 3.8.2, illustrated with Indian evidence.

Article Title: Counting what goes uncounted: strengthening measurement of financial protection in health after the 2025 revision of SDG indicator 3.8.2, with evidence from India

Article References: Sriram, S. (2026). Counting what goes uncounted: strengthening measurement of financial protection in health after the 2025 revision of SDG indicator 3.8.2, with evidence from India. Frontiers in Health Services, 6, Article 1955057. https://doi.org/10.3389/frhs.2026.1955057

Image Credits: AI Generated

DOI: 10.3389/frhs.2026.1955057

Keywords: SDG indicator 3.8.2, financial protection, health financing, catastrophic health expenditure, out-of-pocket spending, forgone care, health insurance, India, universal health coverage, health metrics, Counting, goes

The research compared the designated outcome-based pathway with conventional diagnosis-related group and diagnosis-intervention packet settlement, commonly abbreviated DRG/DIP, in a quasi-experimental study covering eight hospitals, four tertiary and four secondary, between January 2022 and December 2025. January 1, 2024, was treated as the policy cutoff, providing two years of observations before and after implementation. The five eligible cohorts were vertigo, cervical Bi disease, lumbar Bi disease, frozen shoulder and hemorrhoidal disease. These conditions belonged to a local payment catalogue, but the designation “TCM-advantage disease” did not itself demonstrate that traditional Chinese medicine was clinically superior for them.

Researchers linked medical insurance settlement records, discharge abstracts, electronic medical records and patient questionnaires using encrypted identifiers. The administrative cohort included 3,976 cases settled through the outcome-based pathway and 4,009 through conventional DRG/DIP, with 3,922 cases recorded before implementation and 4,063 afterward. A patient-reported survey included 545 respondents, while semi-structured interviews involved three patients, three traditional Chinese medicine clinicians, two hospital insurance managers and two medical insurance administrators. Propensity score matching produced 3,342 cases in each payment group and reduced all measured baseline standardized mean differences below 0.10, improving comparability before the policy-effect estimates were calculated.

The study’s primary measure was a newly constructed Patient-Centered Public Value Index, or PCPVI, combining five domains: health benefit, financial protection, care quality and safety, TCM service provision, and patient experience. A modified Delphi process involving 15 experts assigned weights of 30% to health benefit, 20% each to financial protection and care quality and safety, and 15% each to TCM-specific value and patient experience. All component indicators were placed on a 0–100 scale, with negatively framed measures reverse-coded. Internal consistency was reasonably strong, with a Cronbach’s alpha of 0.82, although the authors cautioned that such statistics alone do not validate the index or establish its clinical interpretability. No minimum important difference has yet been established for the composite score.

After matching, the main difference-in-differences estimate attributed to the payment pathway was a 4.85-point increase in PCPVI, with a 95% confidence interval of 3.32 to 6.38 and p<0.001. Total hospitalization expenditure was 520 RMB lower per admission, with a 95% confidence interval of negative 843 to negative 197 RMB, while out-of-pocket payment was 300 RMB lower, with an interval of negative 480 to negative 120 RMB. The reimbursement ratio rose by 2.40 percentage points, and mean length of stay fell by 0.26 days. Overall satisfaction increased by 0.18 points on the study’s scale. These associations indicate improved measured patient-centered value, but the design cannot eliminate every possible source of unmeasured or time-varying confounding.

Not every outcome changed significantly. The estimated effect on insurance fund payment was negative 130 RMB per admission, but its 95% confidence interval ranged from a 361 RMB reduction to a 101 RMB increase, and p=0.270. The result therefore does not demonstrate insurer savings, budget neutrality or long-term fiscal sustainability. The EQ-5D-5L estimate was 0.021, with a 95% confidence interval of negative 0.001 to 0.043 and p=0.061, so the analysis did not detect a statistically significant change in generic health-related quality of life. Nor were differences in 30-day readmission or in-hospital complications statistically significant. These non-significant findings do not prove equivalence, non-inferiority or the absence of clinically important effects.

Among the 545 survey respondents, those in the outcome-based group reported higher perceived insurance benefit, communication quality, acceptability of traditional Chinese medicine treatment and overall satisfaction. Mean satisfaction was 4.20 versus 4.02 in the conventional group, perceived insurance benefit was 4.06 versus 3.86, communication quality was 4.18 versus 4.02, and treatment acceptability was 4.25 versus 3.95. The groups did not differ significantly on the EQ-5D-5L index, which averaged 0.85 and 0.83, respectively, or on categorical measures of symptom improvement, functional recovery and willingness to choose the pathway again. The EQ visual analogue scale was higher in the outcome-based group, 76.6 versus 74.0, but questionnaires were administered at discharge, limiting conclusions about sustained recovery.

The cost of traditional Chinese medicine rose by 4.90 percentage points as a proportion of total hospitalization expenditure in the outcome-based group, compared with a smaller increase in the conventional group. This shift is a measure of service composition, not proof that additional traditional Chinese medicine produced better clinical outcomes. It could reflect more treatment volume, fewer non-TCM services, price changes or some combination of these. An exploratory analysis excluding TCM cost share from the index still produced a positive policy estimate of 3.72 points, while intensity-defined subgroup results were larger among cases with high TCM spending than among those with low spending. Because payment reform may itself influence spending intensity, and that measure contributes to the index, the contrast cannot establish a dose-response relationship or treatment efficacy.

PCPVI estimates were positive in all five disease cohorts, both age groups, both insurance categories and both hospital levels. The disease-specific estimates ranged from 3.20 points for hemorrhoidal disease to 5.80 points for lumbar Bi disease. Results remained similar under inverse probability weighting, entropy balancing, equal weighting, removal of extreme costs and inclusion of repeated admissions. A placebo policy date produced an estimate of 0.52 points, with a 95% confidence interval of negative 1.11 to 2.15. Although these checks supported the main finding’s stability, they did not prove that the groups followed parallel trends or that the policy cutoff was the only relevant change. National DRG/DIP version 2.0 guidance was also released in 2024, creating a potential source of concurrent policy effects.

Interviews offered context for the measured changes. Six of 10 stakeholders described reduced perceived out-of-pocket burden, seven reported greater recognition of TCM pathway value and five mentioned more standardized clinical pathway management. These accounts were consistent with several quantitative results but did not independently verify them. Implementation also brought burdens: five interviewees raised coding or documentation demands, seven called for dynamic adjustment of payment standards and four expressed concern about hospital cost-control pressure. The conclusions remain limited by the single-city setting, incomplete TCM documentation, possible questionnaire selection bias, 294 matched cases without complete 30-day follow-up, and the absence of long-term clinical and fiscal evaluation. The findings support further testing of outcome-based payment, but not broad claims of TCM-specific effectiveness, insurance savings or transferable policy benefits.

Subject of Research: Evaluation of outcome-based insurance payment for traditional Chinese medicine disease cohorts in Taiyuan, China

Article Title: Aligning insurance payment with public value: outcome-based payment for traditional Chinese medicine advantage diseases under China’s DRG/DIP reform

Article References: Pei, Z., Hu, A., & Duan, Z. (2026). Aligning insurance payment with public value: outcome-based payment for traditional Chinese medicine advantage diseases under China’s DRG/DIP reform. Frontiers in Public Health, 14, Article 1902781. https://doi.org/10.3389/fpubh.2026.1902781

Image Credits: AI Generated

DOI: 10.3389/fpubh.2026.1902781

Keywords: outcome-based payment, DRG/DIP reform, traditional Chinese medicine, patient-centered value, medical insurance, financial protection, difference-in-differences, health services research, patient satisfaction, Aligning, insurance, payment

The study combined 35 in-depth interviews with policymakers, providers and other key stakeholders; an online survey with 94 complete and 18 partial responses; and secondary analysis of national health expenditure data and policy documents. Researchers conducted thematic analysis of the qualitative data using NVivo12 and triangulated findings across the data sources. Georgia was selected as a case in which broad population coverage coexists with high household out-of-pocket spending in the WHO European Region.

Stakeholders described provider responses to financial and competitive pressures that included demand inducement, patient-paid services and commission-based referrals, while survey respondents perceived several of these practices to be common. The findings indicate that out-of-pocket payments are associated with interactions among financing arrangements, provider incentives and regulatory oversight, rather than being attributable only to limited public financing. The authors report that expanding population coverage alone did not ensure financial protection.

The abstract proposes structural changes across health financing, governance and service delivery, including strengthening the purchasing role of the National Health Agency, updating tariffs, expanding the benefit package, regulating market entry and aligning provider incentives. These are the study authors’ policy implications, not evidence that the measures have already reduced out-of-pocket spending. The supplied evidence is limited to the abstract and article overview, so the detailed sample characteristics, survey measures, expenditure results and limitations of the full analysis cannot be independently described here.

Subject of Research: Mixed-methods analysis of persistent out-of-pocket health payments under Georgia’s universal coverage scheme

Article Title: Universal coverage without financial protection: why out-of-pocket payments persist despite universal coverage in Georgia

Article References: Tvaliashvili, M., Sulaberidze, L., Gotsadze, G., Goodman, C., & Hanson, K. (2026). Universal coverage without financial protection: why out-of-pocket payments persist despite universal coverage in Georgia. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15668-8

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15668-8

Keywords: Georgia, universal health coverage, out-of-pocket payments, financial protection, health financing, provider incentives, health regulation, benefit package, mixed methods, health services research, Universal, coverage

Before the uprising in March 2011, Syria was one of the more advanced middle-income settings for cancer care in the Eastern Mediterranean Region. Oncology services were, however, heavily centralized in Damascus, Aleppo, and Latakia. As the conflict escalated between 2011 and 2014, and then internationalized following Russia’s military intervention in 2015, waves of attacks on health infrastructure and shifting lines of territorial control carved the system apart. By the relatively frozen phase between 2020 and 2024, three main configurations had consolidated: a northwest serving roughly five to six million people, a northeast serving around three to four million, and the former government-controlled areas containing about two-thirds of the population and every major city. The northwest and northeast lacked comprehensive cancer services almost entirely, forcing the most severe cases to be referred abroad, particularly to Türkiye, while even the major cities operated under strained conditions with outdated protocols and reliance on unbranded medicines from Iran and India that had not undergone quality control.

The scale of need is substantial and growing. According to Global Cancer Observatory data for 2022, Syria recorded an estimated 22,000 new cancer cases and nearly 14,000 deaths, though these are modelled figures rather than in-country counts, because no functioning national cancer registry existed during the conflict. The authors caution that the true burden is likely higher, given diagnostic gaps, access barriers, and patients who simply never present to care. Around 20 specialized oncology centers operate across several governorates, but the designation is misleading: few facilities offer the full range of surgical, systemic, and radiation treatment within one institution, so patients must piece together their care across multiple sites, often traveling enormous distances at considerable personal cost.

The technical shortfalls described in the article are severe. Only six linear accelerators are available countrywide for radiotherapy, four at Al-Bairuni, of which three are functioning, and two in Lattakia, one of which is out of service. Waiting times of three to six months for radiotherapy are reportedly affecting an estimated 40 percent of urgent cases. CT-PET imaging, essential for accurate diagnosis and staging, is unavailable in the public sector; it exists only in Damascus’s private clinics at prices prohibitive for most patients. There are no operational bone marrow transplantation centers in the country, chemotherapy supply chains are frequently interrupted, and pathology and molecular diagnostic capacity varies widely between facilities. These figures, drawn from ministry-level information, operational reports, and rapid service mapping, are indicative rather than definitive, but they consistently point to a system unable to deliver continuous, multimodal cancer care.

The authors’ central argument is counterintuitive in an emergency: rather than rushing to reopen facilities and expand services, Syria’s early recovery should prioritize governance, referral structure, and financial protection first. They define institutional coherence as the alignment of governance, regulatory, financing, and service delivery structures under a unified national framework, and consolidation as the strategic coordination of services while capacity is rebuilt. Experience from other post-conflict settings supports this sequencing. In Bosnia and Herzegovina, strengthening primary care governance and institutional accountability preceded tertiary expansion and helped restore system coherence. In Liberia, adopting a nationally defined essential health service package aligned implementing partners under shared priorities and reduced fragmentation. Expanding specialized services without stabilizing the institutional architecture, the authors warn, risks reinforcing systemic disorganization and inequity rather than repairing it.

Referral pathways emerge as a critical fault line in the cancer care continuum, the chain running from prevention and early detection through diagnosis, treatment, follow-up, and supportive care. In principle, primary health care should serve as the entry point, applying standardized early detection protocols and distinguishing urgent from routine referrals. In practice, Syria’s primary care system has lost its gatekeeping function. Patients bypass it and self-refer directly to overwhelmed tertiary centers, contributing to diagnostic delays. Many people instead obtain care from pharmacies, community practitioners, and informal providers outside official health system standards, a pattern driven by destroyed facilities, the killing and migration of health workers, and economic hardship.

That dysfunction has deep historical roots, and the article is unusually direct about them. The former regime used health services to reward political loyalty and punish dissent. Before 2011, Latakia and Tartus, areas loyal to the government, had one hospital bed for every 573 and 672 people respectively, compared with 2,113 per bed in Idlib and 1,379 in Al-Raqqa. Workforce data from UNHCR and the World Bank show that doctor density rose in Tartus and Damascus during the war while falling most sharply in Dera’a, Homs, Sweida, rural Damascus, Quneitra, and Deir-ez-Zor. Restoring public confidence in primary care as the gateway to oncology services, the authors argue, therefore requires confronting this inherited inequity head-on, not merely drafting new referral protocols.

Lessons from Liberia and Rwanda suggest that referrals work when they rest on practical mechanisms rather than paperwork alone. In Liberia’s early recovery, compliance improved when district hospitals designated focal persons and communication between referring clinics and receiving facilities was structured rather than informal. Rwanda strengthened referral continuity through clear lines of responsibility between health centers and district hospitals, combined with supervisory follow-up. For Syria, the authors recommend building on the tacit, unwritten knowledge that accumulated across the conflict years: designated referral focal points within oncology centers, streamlined inter-facility communication, and simple confirmation that referred patients actually arrived. Monitoring, they suggest, should start with high-yield indicators such as confirmation of arrival and time to service receipt, before expanding into integrated data platforms. Distance and transport costs compound the problem, as evidence from post-conflict West Africa and from Ukraine, where patients cross regions and borders for unavailable oncology services, both demonstrate.

Financial protection is the third pillar of the proposed strategy, and the authors treat it as a governance instrument rather than a budgetary afterthought. Given Syria’s severe fiscal constraints, universal coverage of oncology benefits is not immediately feasible. Instead, they propose defining a phased essential cancer service package centered on first-line chemotherapy regimens matched to national disease burden and expected survival benefit, in line with the Disease Control Priorities framework, which prioritizes cost-effective, high-impact interventions. Targeted protection for pediatric cancers and curative-intent multimodal care would deliver the greatest mortality reduction while preserving fiscal discipline. Centralizing procurement of essential oncology medicines would reduce stock-outs, price variability, and geographic inequity, while standardized national treatment protocols adapted to available medicines would curb unwarranted variation in prescribing. As fiscal space grows, coverage could broaden progressively.

Perhaps the article’s most important message is that in fragile systems, sequencing is not a retreat from equity but a strategy to protect it. Concentrating complex services temporarily can preserve quality and specialist capacity while the system is rebuilt, provided consolidation is explicitly transitional and paired with a phased decentralization plan as workforce, infrastructure, and financing improve in governorate hospitals. The alternative, rapid expansion on top of fragmented governance, would lock in the very disparities that the war created, leaving patients in peripheral regions traveling vast distances and paying catastrophic costs for incomplete care. Syria’s cancer patients, the authors conclude, need continuity restored across the entire care continuum before capacity can credibly grow, and that continuity depends on aligning governance, service delivery, and financing into a single, accountable national framework.

Subject of Research: Post-conflict reconstruction of cancer care services and health system governance in Syria

Article Title: Rebuilding cancer care in post-conflict Syria: restoring continuity across the cancer care continuum

Article References: Shalabi, S., Abbara, A., Aljerk, W., Debel, J., Safadi, S., Khoshnood, K., Sullivan, R., Ferrouh, Y., & Alkhalil, M. (2026). Rebuilding cancer care in post-conflict Syria: restoring continuity across the cancer care continuum. Frontiers in Cancer Control and Society, 4, Article 1843120. https://doi.org/10.3389/fcacs.2026.1843120

Image Credits: AI Generated

DOI: 10.3389/fcacs.2026.1843120

Keywords: Syria, cancer care, oncology, health system fragmentation, post-conflict recovery, referral pathways, radiotherapy, health financing, cancer registry, health governance, primary health care, financial protection

The stakes of this question are enormous. Out-of-pocket expenditure remains one of the most stubborn barriers to healthcare access across India, and it falls hardest on households in low-income districts like Murshidabad, where a single hospitalization can erase years of savings. Publicly funded health insurance has been promoted as a central instrument of universal health coverage in low- and middle-income countries, and West Bengal’s Swasthya Sathi Scheme is among the largest state-level experiments in this approach. Yet the gap between a scheme on paper and a scheme in practice is where most such programmes succeed or fail. Understanding that gap requires talking to the people who queue at enrolment camps, carry smart cards to hospital counters, and process claims behind the scenes, which is precisely what this study set out to do.

Between December 2024 and March 2025, the research team conducted 28 in-depth interviews in Murshidabad district: 16 with beneficiaries who had actually used the scheme and 12 with individuals involved in its implementation at the hospital, block and sub-divisional levels. Participants were recruited through purposive sampling, a technique that deliberately selects informants with direct experience of the phenomenon under study rather than relying on random selection. The interviews were conducted in Bengali, audio-recorded, transcribed verbatim and translated into English before being analysed thematically using ATLAS.ti version 8, a software platform widely used to code and organize qualitative data. The study was approved by the Institutional Review Committee and the Institutional Ethics Committee of Kasturba Medical College, Manipal Academy of Higher Education, and reported in line with the COREQ standards for qualitative research, lending the work a methodological transparency that strengthens confidence in its findings.

From this body of testimony, five major themes crystallized: awareness, accessibility and scheme coverage; delivery of scheme services and healthcare utilization; coordination and support systems; health-seeking behaviour and scheme enablers; and challenges in scheme access and implementation. The architecture of these themes matters because it maps the full journey of a patient through the system, from first hearing about the insurance card to navigating a hospital admission and, in some cases, hitting a wall of bureaucratic or social resistance. Rather than treating utilization as a single yes-or-no outcome, the thematic structure reveals how each stage of the patient pathway carries its own vulnerabilities, and how a failure at any one of them can prevent a family from converting an entitlement on paper into care at the bedside.

The most consistent finding was the scheme’s perceived value as a financial shield. Beneficiaries described Swasthya Sathi as an important source of support that measurably improved their access to healthcare, particularly for costly treatments and surgical procedures that would otherwise have been catastrophic expenses. This is the core promise of cashless insurance: the patient presents the card, the hospital bills the insurer directly, and the family walks out without a debt. For households in a district where income is often precarious and seasonal, that mechanism transforms the calculus of whether to seek care at all. The researchers found that this financial protection was not an abstract benefit but a lived experience, recounted by families who had faced exactly the kind of high-cost medical events that the scheme was built to absorb.

Three facilitators of utilization stood out in the testimony. Community-level enrolment camps brought registration directly into villages, sparing families the cost and complexity of travelling to government offices. The involvement of local stakeholders, including frontline workers and block-level officials, created trusted human channels through which information about the scheme could flow. And the cashless design of the programme itself was repeatedly identified as a decisive enabler, because it removed the need for families to find money upfront at the moment of illness, when liquidity is scarcest. Together, these findings suggest that the last-mile infrastructure of a health insurance scheme, the camps, the local intermediaries and the payment architecture, can matter as much as the headline coverage figure printed on the card.

Yet the study is equally candid about the obstacles. Participants reported limited awareness of what the scheme actually entitles them to, a gap that leaves many beneficiaries unsure which services are covered, where they can be accessed and what documentation is required. Card-related issues emerged as a recurring irritant, ranging from problems obtaining or updating cards to difficulties at the point of use. Operational constraints within the implementation machinery, including staffing and coordination challenges across hospital, block and sub-divisional levels, added further friction. The researchers also documented socio-cultural barriers that shaped who could reach care and how, underscoring that health insurance utilization is never purely an administrative problem but is embedded in family dynamics, gender norms and community expectations.

These implementation challenges carry a technical lesson for health systems researchers. A cashless insurance scheme is, in essence, a chain of dependent processes: enrolment, card issuance, verification at the facility, claim processing and grievance redress. Each link depends on information flowing correctly, and the Murshidabad findings show that breakdowns cluster precisely where information asymmetries are greatest, at the boundary between beneficiaries and the bureaucracy. One-time-password-based verification, unique registration numbers and card infrastructure all assume a level of digital literacy and administrative support that is unevenly distributed in rural populations. When a beneficiary does not know an entitlement exists, or cannot resolve a card error, the coverage ceiling of 500,000 rupees is irrelevant; the effective coverage is zero.

The study’s conclusions are measured but pointed. The Swasthya Sathi Scheme was perceived as an important mechanism for improving access to healthcare and reducing financial burden in Murshidabad district, and beneficiaries reported broadly positive experiences. At the same time, the researchers emphasize that several implementation challenges continue to affect utilization, and they highlight the importance of awareness, community engagement and effective administrative processes in supporting publicly funded health insurance programmes. In other words, the scheme works where its human and procedural infrastructure works, and falters where that infrastructure thins out. This framing shifts the policy conversation away from whether large-scale cashless insurance can protect poor households, toward the more actionable question of how to harden the enrolment, information and support systems that determine whether protection reaches everyone.

For the wider field of universal health coverage, the Murshidabad evidence arrives at a moment when governments across low- and middle-income countries are scaling up similar programmes and searching for implementation evidence rather than headline statistics. The study’s method, pairing beneficiary voices with stakeholder perspectives across multiple administrative tiers, offers a replicable template for diagnosing where a scheme leaks value. Its message is deceptively simple: a health insurance card is only as strong as the awareness, trust and administrative machinery behind it. In Murshidabad, that machinery has demonstrably lifted families over the financial cliff of major illness, and, with targeted investment in awareness and card support, could carry the scheme’s promise to the many beneficiaries for whom it remains, for now, a card they hold but cannot fully use.

Subject of Research: Utilization and implementation of the Swasthya Sathi cashless health insurance scheme in Murshidabad district, West Bengal, India

Article Title: Beneficiary and stakeholder perspectives on the utilization and implementation of the Swasthya Sathi Scheme in Murshidabad District, West Bengal, India: a qualitative study

Article References: Sultana, N., Prabhu, V., Jahangir, S., & Sumit, K. (2026). Beneficiary and stakeholder perspectives on the utilization and implementation of the Swasthya Sathi Scheme in Murshidabad District, West Bengal, India: a qualitative study. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15731-4

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15731-4

Keywords: Swasthya Sathi Scheme, health insurance, out-of-pocket expenditure, universal health coverage, West Bengal, India, qualitative research, health services research, financial protection, healthcare access, implementation challenges, Murshidabad

The methodological architecture of the review is itself instructive. The researchers searched six major electronic databases, including PubMed, Scopus, Web of Science, Embase, EconLit, and PAIS, along with four sources of grey literature, capturing material published up to April 29, 2026. From an initial pool of 3,455 records, the screening process distilled the evidence down to 27 studies. Each was appraised for methodological quality using tools matched to its design: the Joanna Briggs Institute checklist, the Mixed Methods Appraisal Tool, and the AACODS checklist designed for grey literature, which evaluates authority, accuracy, coverage, objectivity, date, and significance. The search strategy itself was peer-reviewed against the PRESS standard, and the review was registered prospectively, in line with PRISMA 2020 reporting guidelines. Twenty-three of the included studies were judged to be of high quality and four of moderate quality, a distribution that lends considerable weight to the synthesis that follows.

The analytical framework at the heart of the paper is the so-called ‘abc’ structural model, which dissects health financing institutions into three interacting layers: policy goals, institutional tasks, and organizational positions. By measuring the degree of alignment among these layers, the authors could quantify what they call structural misalignment, expressed as a delta-E value greater than zero. The headline finding is sobering: 89 percent of the included studies, 24 of 27, documented such misalignment, and the pattern held regardless of study quality rating. In practical terms, this means that in nearly every crisis examined, the goals that governments articulated for their health systems were not matched by the institutional tasks those systems were actually equipped to perform, and those tasks in turn were not supported by the organizational mandates and resources assigned to them. The result is a chronic gap between what health financing systems promise and what they can deliver under fiscal stress.

The review identifies distinct shock profiles with distinct consequences. International sanctions, for example, predominantly disrupted pharmaceutical supply chains, choking off access to essential medicines through banking restrictions, import controls, and the withdrawal of international suppliers unwilling to navigate compliance risk. Currency collapses operated through a different channel, eroding the revenue base of the health sector itself. When a national currency loses most of its value, government budgets denominated in that currency can no longer purchase imported drugs, equipment, and vaccines priced in hard currency, while salaried health workers see the real value of their wages evaporate. These two mechanisms, supply-side strangulation and revenue erosion, recur across the region’s crisis episodes and interact in ways that compound each other, leaving health systems simultaneously poorer and less able to convert whatever resources remain into effective services.

Perhaps the most consequential finding concerns risk pooling, the mechanism by which health financing systems spread financial risk across populations instead of leaving individuals to bear the full cost of illness. In Lebanon and Jordan, the review found that fragmented risk pooling, in which multiple small, poorly coordinated insurance schemes cover separate slices of the population, exacerbated what the authors describe as health poverty during crises. Fragmentation matters because small pools lack the reserves and bargaining power to absorb shocks. When an economic crisis hits, households covered by weak or fragmented schemes are forced back onto out-of-pocket payments, and out-of-pocket spending is the financing mechanism most strongly associated with catastrophic health expenditure, the technical term for medical costs so high they push households into destitution or force them to forgo care entirely. The WANA evidence suggests that the architecture of pooling, not merely the level of funding, determines whether a health system bends or breaks under macroeconomic pressure.

What, then, can be done? The authors argue that two structural reforms stand out. The first is redesigning institutional tasks, the M2 component of their structural model, so that the day-to-day functions of health financing bodies actually correspond to stated policy goals rather than drifting into misalignment. The second is establishing automatic counter-cyclical financing mechanisms, pre-legislated arrangements that channel additional resources into health when the economy contracts, without requiring ad hoc political decisions in the middle of a crisis. The logic is analogous to automatic stabilizers in fiscal policy: because crises arrive suddenly and political attention is scarce precisely when need is greatest, the protective response should be built into the system in advance. Without such mechanisms, health budgets in the region have tended to be cut procyclically, falling exactly when demand for publicly financed care rises.

The regional focus of the review deserves emphasis. WANA countries occupy an uncomfortable position in global health economics: many are middle-income states with sophisticated health infrastructure but acute exposure to geopolitical and macroeconomic volatility. Sanctions regimes, oil price swings, conflict, refugee flows, and currency instability have produced repeated fiscal shocks over the review’s 2008 to 2026 window. The authors frame the stakes in systemic terms, warning that policymakers must align macro-fiscal mandates with health sector positions to prevent systemic collapse during economic shocks. That phrasing reflects a growing recognition in the health policy literature that health system resilience is not simply a matter of clinical capacity or emergency preparedness, but of the financial plumbing that determines whether money reaches services when the broader economy is in free fall.

The review also contributes to a methodological conversation about how such evidence is produced. The authors disclose that a large language model was used during manuscript preparation for language editing and for optimizing the syntax of the systematic review search strategy, with all AI-generated suggestions critically reviewed and verified by the human authors, who retain full responsibility for the content. No AI tool was used to generate original research data, analysis, or scientific conclusions. The research received no specific grant from any funding agency in the public, commercial, or not-for-profit sector, and the authors declare no competing interests. The study protocol was reviewed by the Ethics Committee of Shiraz University of Medical Sciences, and because the work synthesizes publicly available secondary data, formal ethical approval for primary human research was not required.

For the wider field, the implications extend well beyond the region studied. Low- and middle-income countries everywhere face the twin pressures of constrained fiscal space and rising health needs, and the WANA experience functions as a stress test of health financing theory under extreme conditions. The finding that structural misalignment is nearly universal in crisis settings suggests that incremental budget adjustments are insufficient; what is required is institutional redesign that hard-wires financial protection into the architecture of the system. The review’s call for automatic counter-cyclical mechanisms echoes a broader movement toward resilience-oriented health financing, in which the goal is not merely efficiency in calm times but survivability in stormy ones. As economic volatility becomes a defining feature of the global landscape, the lessons distilled from these 27 studies offer a warning and a template in equal measure: health systems that fail to align their goals, tasks, and organizational mandates will pay for that misalignment in the currency of human health, and the poorest households will pay first.

Subject of Research: Health financing policy responses to economic crises in West Asian and North African countries

Article Title: Health financing policy responses to economic crises in WANA countries: a systematic review (2008–2026)

Article References: Kharazmi, E., Lotfi, F., Azizi, N., Ostovar, S., & Kharazmi, A. (2026). Health financing policy responses to economic crises in WANA countries: a systematic review (2008–2026). BMC Health Services Research. https://doi.org/10.1186/s12913-026-15743-0

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15743-0

Keywords: health financing, economic crisis, health system resilience, West Asia and North Africa, financial protection, risk pooling, universal health coverage, sanctions, currency devaluation, catastrophic health expenditure, health policy, systematic review

The research was conducted by a team affiliated with the Lancet Oncology Commission on the Human Crisis in Cancer, an initiative launched to quantify and correct the growing imbalance between biomedical investment and the human dimensions of oncology. Using data from the 2023 global review by the International Cancer Control Partnership, the researchers screened a standardized questionnaire of 95 items and identified 20 questions relevant to five Commission domains: compassionate care models, human-centred metrics, equitable access to psychosocial and palliative services, workforce and education reform, and value-aligned governance. Those items were then mapped into six analytical themes spanning sociocultural factors, systems of care, medical education, economic protection, mental health and palliative care.

The single most striking finding concerns who gets a seat at the table. Although 93 percent of the plans reported that stakeholders were involved in their development, only 12 percent identified people living with cancer as stakeholders. Governmental, professional and institutional actors dominate cancer planning almost everywhere, meaning the very documents that set national priorities rarely reflect the priorities of the people they are meant to serve. The authors point to power imbalances, funding and time constraints, and simple lack of awareness as likely barriers, and note that World Health Organization guidance explicitly calls for engaging patient groups in national cancer control planning.

The income gradient in the data is stark. On average, human-centred themes appeared in 44 percent of plans from upper-middle and high-income countries but only 32 percent of plans from lower-middle and low-income countries. Medical education was the exception that proved the rule: 96 percent of countries with dedicated cancer plans included workforce development or provider training, with no significant difference between income groups. But the content of that training was overwhelmingly biomedical. Oncologists, pathologists and surgical specialists featured prominently, while psychosocial support training appeared in just 16 percent of plans, community health worker training in 12 percent, and patient navigator training in a mere 4 percent.

Economic protection emerged as perhaps the most neglected theme of all. Only 13 percent of plans included strategies to shield patients from catastrophic health expenditure — typically defined as spending more than 30 percent of household income on cancer-related costs — and the figure was essentially flat across income levels, with high-income countries actually among the least likely to include such provisions. Universal health coverage strategies appeared in just 26 percent of plans overall. Given that financial toxicity is a well-established driver of cancer inequity, treatment abandonment and poorer outcomes, the authors argue that this neglect represents a fundamental misalignment between policy and patient need.

Mental health provisions fared little better. While 72 percent of countries with cancer plans included strategies to support families or caregivers of patients in active treatment, only 3 percent of all plans referenced essential medicines for treating psychological distress such as anxiety, depression and delirium — the least frequently included item in the entire analysis. Post-treatment survivorship care appeared in 80 percent of high-income country plans but only 25 percent of low-income country plans, a difference that was highly statistically significant. This gap is particularly concerning given the documented burden of depression among cancer patients, which is highest on the African continent at a pooled prevalence of 35 percent, compared with 25 percent in North America, and given established links between psychological distress, quality of life, treatment adherence and survival.

Palliative care was the strongest-performing human-centred theme, appearing in an average of 65 percent of plans, with pain management strategies present in 62 percent and no significant income-based differences. Yet even here the picture is incomplete: patient navigation — the practice of guiding patients through screening, treatment, financial assistance and supportive services — was included in 42 percent of plans overall but dropped to around 11 percent in lower-income settings, precisely where late-stage presentation is most common and navigation may deliver the greatest benefit. In many African countries, up to 80 percent of patients present with locally advanced or metastatic disease at diagnosis, making supportive and navigational infrastructure not a luxury but a necessity.

The authors are careful to spell out what their analysis can and cannot show. Roughly 18 percent of WHO Member States lacked publicly available plans, and the study measured policy intent rather than implementation, funding or patient outcomes. A plan’s silence on psychosocial care does not prove the absence of services, since mental health or financial protection may be addressed through separate national health or universal coverage policies. Countries were weighted equally regardless of population, so the figures describe the proportion of countries rather than the proportion of people covered. In conflict-affected states, a plan can look comprehensive on paper while the health system it describes barely functions. Still, the consistency of the gaps across regions and income levels suggests a genuine structural blind spot rather than a documentation artifact.

The study’s conclusions align with the Commission’s broader call to rehumanize cancer care. Its recommendations include embedding scalable patient navigation — particularly financial navigation — into national plans, strengthening structural supports for caregivers, guaranteeing access to essential psychotropic medicines, reforming workforce training to include psychosocial competencies, and shifting governance toward value-aligned, equity-oriented models. The authors also propose that future iterations of the assessment instrument move beyond binary yes-or-no questions to capture whether commitments are actually costed, assigned to an agency, implemented and monitored, with equity-stratified indicators and patient-reported experience measures built in.

What makes the findings resonate beyond oncology is what they reveal about how health systems value intangible goods. Machines, drugs and screening programs are easy to cost, procure and count; compassion, dignity and psychological safety are not. The analysis suggests that unless national strategies explicitly name and resource the human dimensions of cancer care, those dimensions will continue to lose out in budget negotiations and implementation plans — and the patients who bear the heaviest burden of advanced disease, poverty and psychological distress will continue to be the least likely to receive them. The authors’ message to policymakers is blunt: a cancer strategy that plans only for the tumor, and not for the person, is an incomplete strategy.

Subject of Research: Global policy analysis of human-centred cancer care in national cancer strategy plans

Article Title: A cross-sectional global policy analysis of the human gap in 156 national cancer strategy plans

Article References: Lau, E., Shapiro, G. K., Rodin, G., Sullivan, R., Bhoo-Pathy, N., Unger-Saldaña, K., Trapani, D., Salins, N., Skelton, M., & Li, M. (2026). A cross-sectional global policy analysis of the human gap in 156 national cancer strategy plans. eClinicalMedicine, 100, Article 104244. https://doi.org/10.1016/j.eclinm.2026.104244

Image Credits: AI Generated

DOI: 10.1016/j.eclinm.2026.104244

Keywords: national cancer control plans, human-centred care, psychosocial support, palliative care, patient navigation, health equity, financial protection, mental health, cancer policy, low-income countries, Lancet Oncology Commission, eClinicalMedicine